ProVation Clinic Note and ProVation Order Sets, powered by UpToDate Decision Support, to be Integrated into NextGen Now Platform
Wolters Kluwer, a leading global provider of information for healthcare professionals and students, announced today that NextGen Healthcare will integrate ProVation® Clinic Note into NextGen Now™, the company's new cloud-based electronic health record (EHR) platform.
ProVation Clinic Note is composed of more than 8,000 evidence-based and pre-coded templates and accompanying metadata that enable content presented to the clinician to change based on the patient's age, gender, reason for visit, clinical venue and physician specialty. The addition of ProVation Clinic Note to NextGen Now provides users of the cloud-based ambulatory EHR platform access to "smart documentation" that is integrated with key components of the patient's electronic record. It also features clinical decision support (CDS) rules to enhance delivery of evidence-based care.
Designed for integration by EHR vendors into physician documentation modules, Clinic Note enables smart documentation through rules and tagging that drive clinicians to the most appropriate and efficient documentation and order set content for the patient. It also integrates with other components of the EHR including the Problem List and Medication List, and drives smart coding including E&M, ICD-9, ICD-10, SNOMED CT, LOINC and RxNorm.
"The practice of medicine is constantly evolving, and clinicians are in search of better ways to leverage healthcare IT to remain current with evidence-based practices and with current regulatory and quality processes," said Sarah Corley, MD, FACP, Chief Medical Officer for NextGen Healthcare. "Wolters Kluwer shares our commitment to providing the industry with the tools needed to improve outcomes through customized, evidence-based care. By integrating smart documentation and evidence-based decision support into the new platform, our clients will be well equipped to streamline clinical processes and improve overall quality and compliance."
"This partnership with NextGen demonstrates not only our commitment to meeting the needs of EHR vendors and end users, but also the value clinicians place on the quality and breadth of our clinical content and CDS," said Arvind Subramanian, President and CEO, Wolters Kluwer Health, Clinical Solutions. "It is a natural joining of two companies that place a high value on accelerating the industry's move from unstructured text to codified data and decision support tools that drive the analytics necessary to succeed in an increasingly value-based care market."
NextGen Healthcare will also integrate the ambulatory order set templates from ProVation Order Sets into NextGen Now to provide CDS rules and care protocols that help clinicians deliver evidence-based care. ProVation Order Sets improves patient outcomes and quality of care by providing evidence-based order set templates developed with the editors of UpToDate®, the clinical decision support resource of choice for more than 1 million users worldwide.
About NextGen Healthcare
NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, connectivity and financial solutions, including revenue cycle management services for ambulatory, inpatient and dental provider organizations. For more information, visit www.nextgen.com and www.qsii.com. Follow us on Twitter, Facebook, LinkedIn and YouTube.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.